# Ibex Medical Analytics vs Lunit

Ibex Medical Analytics records 9,117 monthly visits with -3% month-over-month growth and Contact for Pricing pricing. Lunit records 29,181 monthly visits with -12.8% growth and Contact for Pricing pricing.

| Metric | [Ibex Medical Analytics](https://openaitools.app/tool/ibex-ai-com) | [Lunit](https://openaitools.app/tool/lunit) |
| :--- | :--- | :--- |
| Website URL | https://ibex-ai.com | https://www.lunit.io/en |
| Categories | AI Medical Diagnosis, AI Healthcare, AI Assistant, AI Image Recognition | AI Healthcare, AI Medical Diagnosis, AI Image Recognition |
| Pricing Model | Contact for Pricing | Contact for Pricing |
| Monthly Visits | 9,117 | 29,181 |
| MoM Growth Rate | -3% | -12.8% |
| Primary Market | Israel | South Korea |
| Direct Visits | 3,071 | 8,314 |
| Review Score | 4.6 | 4.6 |
| Saved Count | 0 | 1 |
| Supported Platforms | Website | Website |

## Ibex Medical Analytics

Ibex provides AI-based cancer diagnostics built for pathology labs, hospitals, and health systems that have moved to digital slides. Whole-slide images are scanned, then Ibex algorithms analyse the tissue and flag regions of interest, produce measurements, and generate structured, synoptic reporting data. Because it plugs into existing digital pathology scanners and viewers, it acts as a decision-support layer rather than a replacement for the pathologist.

The product family, marketed under the Galen name, targets specific diagnostic tasks such as prostate biopsy grading, breast cancer detection, and gastric cancer detection, along with tools for quality control and case prioritisation. The goal is to reduce diagnostic variability, cut review time, and help labs keep pace with rising caseloads and shrinking specialist workforces.

Ibex is aimed at organisations rather than individuals, so pricing is generally arranged through a tailored quote based on scanner fleet, case volume, and modules selected. Exact figures are not published publicly.

**Pricing & Plans:** Enterprise/contact-for-pricing model. Pricing is arranged via a custom quote based on lab size, slide volume, and the Galen modules deployed; no public price list.

- **AI cancer detection algorithms:** Deep-learning models analyse whole-slide images to spot suspicious tissue regions and support earlier, more consistent cancer detection.
- **Galen platform suite:** Purpose-built modules for prostate, breast, and gastric cancer workflows, covering detection, grading, and reporting support.
- **Fits digital pathology workflows:** Designed to integrate with common scanners, slide viewers, and lab information systems so it works alongside existing infrastructure.
- **Structured reporting output:** Generates measurements and synoptic-style data that feed directly into reports, reducing manual documentation effort.
- **Case prioritisation and QC:** Helps labs triage and quality-check cases so urgent or borderline slides get expert attention sooner.

**Strengths:** Targets concrete diagnostic tasks with clinically-oriented detection and grading support; Integrates with existing digital pathology scanners and viewers rather than replacing them; Aims to reduce variability and speed up reporting for high-volume cancer screening; Backed by peer-reviewed research and deployments in major hospital networks

**Limitations:** No public pricing; requires a sales conversation and custom quote; Value depends on the lab already having a digital pathology scanning setup; Not a consumer or self-serve tool, so individuals cannot try it directly

[Profile (Markdown)](https://openaitools.app/tool/ibex-ai-com.md)

## Lunit

Lunit is a medical AI company headquartered in Seoul, South Korea, spun out of deep-learning research and focused squarely on oncology. Rather than chasing general-purpose healthcare AI, it has built two connected product families: one that helps clinicians find cancer earlier in imaging, and one that extracts quantitative biology from tissue to guide treatment and drug development. Its technology is used across a large international footprint spanning more than 10,000 customer sites in over 70 countries, with hundreds of peer-reviewed publications and industry partnerships behind the deployments.

On the screening side, the Lunit INSIGHT family analyzes mammograms and chest radiographs. Lunit INSIGHT MMG handles 2D mammography while Lunit INSIGHT DBT covers 3D breast tomosynthesis, both designed to flag suspicious regions so radiologists can prioritize the studies that need attention most. Lunit INSIGHT CXR does the same for chest X-rays. Around these detection engines Lunit has assembled program-level tooling: density assessment, risk assessment and risk pathways, live mammography reporting, quality management, analytics, and a patient hub, so a screening service can run AI as part of its routine rather than as an isolated experiment.

On the precision oncology side, the Lunit SCOPE portfolio analyzes pathology images. Lunit SCOPE IO quantifies the tumor microenvironment and immune cell infiltration, which matters for immunotherapy strategy, while the Lunit SCOPE IHC Suite supports immunohistochemistry quantification across markers such as HER2 and PD-L1, alongside a genotype prediction tool. These products are aimed at biopharma partners, clinical trial teams, and companion diagnostic development, where reproducible quantitative readouts are the bottleneck. Because Lunit sells to hospitals, screening programs, and pharmaceutical companies, pricing is quoted directly rather than published, and regulatory status differs by market.

**Pricing & Plans:** Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

- **Lunit INSIGHT MMG and DBT:** Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings.
- **Lunit INSIGHT CXR:** Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows.
- **Lunit SCOPE IO:** Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research.
- **Lunit SCOPE IHC Suite:** AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring.
- **Screening analytics and workflow tools:** Live mammography reporting, risk assessment, risk pathways, quality management, and patient-facing tools that embed AI into the wider screening program.

**Strengths:** Clinically validated radiology AI with documented regulatory clearances and published evidence; Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship; Wide real-world adoption across many countries, which means integrations and workflow lessons already exist; Strong research output and biopharma partnerships support credibility for trial and CDx work

[Profile (Markdown)](https://openaitools.app/tool/lunit.md)

## Frequently Asked Questions

### How do Ibex Medical Analytics and Lunit compare in monthly traffic?

Ibex Medical Analytics has 9,117 monthly visits, while Lunit has 29,181. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Ibex Medical Analytics has a month-over-month growth rate of -3%; Lunit has -12.8%.

### How does pricing compare?

Ibex Medical Analytics: Contact for Pricing. Enterprise/contact-for-pricing model. Pricing is arranged via a custom quote based on lab size, slide volume, and the Galen modules deployed; no public price list. Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 2 | [ScanSkinAI](https://openaitools.app/tool/scanskinai) | 265,770 | -10.9% | Freemium, Paid | Free AI skin and mole scanning with optional dermatologist review | [.md](https://openaitools.app/tool/scanskinai.md) |
| 3 | [Overjet](https://openaitools.app/tool/overjet-ai) | 256,150 | +12.6% | Contact for Pricing | FDA-cleared dental AI for diagnostics, imaging, and insurance workflow | [.md](https://openaitools.app/tool/overjet-ai.md) |
| 4 | [Pearl](https://openaitools.app/tool/hellopearl-com) | 221,155 | -7.6% | Contact for Pricing | FDA-cleared dental AI for sharper diagnosis and a smoother front office | [.md](https://openaitools.app/tool/hellopearl-com.md) |
| 5 | [0xmd](https://openaitools.app/tool/0xmd-com) | 128,262 | -2.2% | Freemium | Generative AI for medical and everyday health questions | [.md](https://openaitools.app/tool/0xmd-com.md) |
| 6 | [CT Read](https://openaitools.app/tool/ct-read) | 103,157 | -5.8% | Paid | AI analysis that turns X-rays, CT scans, MRI and ultrasound into plain-language reports | [.md](https://openaitools.app/tool/ct-read.md) |
| 7 | [Glass Health](https://openaitools.app/tool/glass-health) | 41,068 | -52.2% | Contact for Pricing | Frontier clinical AI grounded in leading medical evidence | [.md](https://openaitools.app/tool/glass-health.md) |
| 8 | [Oatmeal Health](https://openaitools.app/tool/oatmeal-health) | 40,264 | -44.9% | Contact for Pricing | AI lung cancer screening that finds eligible patients and scores every nodule | [.md](https://openaitools.app/tool/oatmeal-health.md) |
| 9 | [RapidAI](https://openaitools.app/tool/rapidai-com) | 20,172 | -27.9% | Contact for Pricing | Enterprise clinical AI that turns medical imaging into faster, more confident care decisions. | [.md](https://openaitools.app/tool/rapidai-com.md) |
| 10 | [Healz.AI](https://openaitools.app/tool/healz-ai) | 12,433 | -47.4% | Freemium, Free Trial, Paid | AI case review for cancer and complex conditions, with human oncologists in the loop | [.md](https://openaitools.app/tool/healz-ai.md) |

---
Source: https://openaitools.app/compare/ibex-ai-com-vs-lunit

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
